Half-year report · Q2
4565.TEDINET S100WI6F
Period2025-01-01 → 2025-06-30
Filed2025-08-08
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥15.1bn | 2025-01-01 → 2025-06-30 | Cons. | Revenue IFRS |
| Revenue | ¥28.8bn | 2024-01-01 → 2024-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥12.7bn | 2024-01-01 → 2024-06-30 | Cons. | Revenue IFRS |
| Operating income | −¥2.8bn | 2025-01-01 → 2025-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | −¥3.7bn | 2024-01-01 → 2024-06-30 | Cons. | Operating profit loss IFRS |
| Profit before tax | −¥3.7bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | −¥4.7bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | −¥3.2bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss before tax IFRS |
| Net income (owners) | −¥3.1bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | −¥4.8bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | −¥4.7bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | −¥3.1bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss IFRS |
| Net income | −¥4.7bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss IFRS |
| Total assets | ¥144.7bn | at 2025-06-30 | Cons. | Assets IFRS |
| Total assets | ¥151.5bn | at 2024-12-31 | Cons. | Assets IFRS |
| Total assets | ¥156.5bn | at 2024-06-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥78.8bn | at 2025-06-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥83.0bn | at 2024-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥65.9bn | at 2025-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥68.5bn | at 2024-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥69.0bn | at 2024-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥66.8bn | at 2023-12-31v | Cons. | Equity IFRS |
| Equity (owners) | ¥65.9bn | at 2025-06-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥68.5bn | at 2024-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥69.0bn | at 2024-06-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥33.0bn | at 2025-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥32.3bn | at 2024-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥51.0bn | at 2024-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥49.1bn | at 2023-12-31v | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥433m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | −¥7.7bn | 2024-01-01 → 2024-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥1.5bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | ¥3.5bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥4.8bn | 2024-01-01 → 2024-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | ¥434m | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥3.4bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥6.9bn | 2024-01-01 → 2024-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥3.5bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥-34.82 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥-53.92 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥-52.51 | 2024-01-01 → 2024-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥-34.82 | 2025-01-01 → 2025-06-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥-53.92 | 2024-01-01 → 2024-12-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥-52.51 | 2024-01-01 → 2024-06-30 | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 45.5% | at 2025-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 45.2% | at 2024-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 44.1% | at 2024-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 537
| Item | Context | Value | Unit |
|---|---|---|---|
| Purchase of intangible assets inv cf IFRS | Prior1YTDDuration | -3000000 | JPY |
| Net decrease increase in time deposits inv cf IFRS | CurrentYTDDuration | 3850000000 | JPY |
| Net decrease increase in time deposits inv cf IFRS | Prior1YTDDuration | － | JPY |
| Proceeds from contingent consideration inv cf IFRS | CurrentYTDDuration | － | JPY |
| Proceeds from contingent consideration inv cf IFRS | Prior1YTDDuration | 379000000 | JPY |
| Other inv cf IFRS | CurrentYTDDuration | 17000000 | JPY |
| Other inv cf IFRS | Prior1YTDDuration | 160000000 | JPY |
| Net cash provided by used in investing activities IFRS | CurrentYTDDuration | 3515000000 | JPY |
| Net cash provided by used in investing activities IFRS | Prior1YTDDuration | 434000000 | JPY |
| Repayments of long term borrowings fin cf IFRS | CurrentYTDDuration | -2900000000 | JPY |
| Repayments of long term borrowings fin cf IFRS | Prior1YTDDuration | -2900000000 | JPY |
| Repayments of lease obligations fin cf IFRS | CurrentYTDDuration | -450000000 | JPY |
| Repayments of lease obligations fin cf IFRS | Prior1YTDDuration | -447000000 | JPY |
| Payments for early redemption of bonds fin cf IFRS | CurrentYTDDuration | － | JPY |
| Payments for early redemption of bonds fin cf IFRS | Prior1YTDDuration | -150000000 | JPY |
| Other fin cf IFRS | CurrentYTDDuration | -0 | JPY |
| Other fin cf IFRS | Prior1YTDDuration | -1000000 | JPY |
| Net cash provided by used in financing activities IFRS | CurrentYTDDuration | -3350000000 | JPY |
| Net cash provided by used in financing activities IFRS | Prior1YTDDuration | -3498000000 | JPY |
| Effect of exchange rate changes on cash and cash equivalents IFRS | CurrentYTDDuration | 131000000 | JPY |
| Effect of exchange rate changes on cash and cash equivalents IFRS | Prior1YTDDuration | 3472000000 | JPY |
| Net increase decrease in cash and cash equivalents IFRS | CurrentYTDDuration | 729000000 | JPY |
| Net increase decrease in cash and cash equivalents IFRS | Prior1YTDDuration | 1919000000 | JPY |
| Cash and cash equivalents IFRS | Prior1YearInstant | 32268000000 | JPY |
| Cash and cash equivalents IFRS | Prior2YearInstant | 49065000000 | JPY |
| Cash and cash equivalents IFRS | CurrentQuarterInstant | 32997000000 | JPY |
| Cash and cash equivalents IFRS | Prior1QuarterInstant | 50984000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2025-08-08 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第36期中(自 2025年１月１日 至 2025年６月30日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)ネクセラファーマ株式会社 | |
| Company name in english cover page | FilingDateInstant | Nxera Pharma Co., Ltd. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表執行役社長CEO クリストファー・カーギル | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都港区赤坂九丁目７番２号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)03(5962)5718 (代表) | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)チーフ・アカウンティング・オフィサー キーラン・ジョンソン | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都港区赤坂九丁目７番２号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)03(5962)5718 (代表) | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)チーフ・アカウンティング・オフィサー キーラン・ジョンソン | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E00981 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 45650 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)ネクセラファーマ株式会社 | |
| Filer name in english | FilingDateInstant | Nxera Pharma Co., Ltd. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |